Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 14;9(12):280.
doi: 10.3390/jimaging9120280.

Convolutional Neural Network Model for Segmentation and Classification of Clear Cell Renal Cell Carcinoma Based on Multiphase CT Images

Affiliations

Convolutional Neural Network Model for Segmentation and Classification of Clear Cell Renal Cell Carcinoma Based on Multiphase CT Images

Vlad-Octavian Bolocan et al. J Imaging. .

Erratum in

Abstract

(1) Background: Computed tomography (CT) imaging challenges in diagnosing renal cell carcinoma (RCC) include distinguishing malignant from benign tissues and determining the likely subtype. The goal is to show the algorithm's ability to improve renal cell carcinoma identification and treatment, improving patient outcomes. (2) Methods: This study uses the European Deep-Health toolkit's Convolutional Neural Network with ECVL, (European Computer Vision Library), and EDDL, (European Distributed Deep Learning Library). Image segmentation utilized U-net architecture and classification with resnet101. The model's clinical efficiency was assessed utilizing kidney, tumor, Dice score, and renal cell carcinoma categorization quality. (3) Results: The raw dataset contains 457 healthy right kidneys, 456 healthy left kidneys, 76 pathological right kidneys, and 84 pathological left kidneys. Preparing raw data for analysis was crucial to algorithm implementation. Kidney segmentation performance was 0.84, and tumor segmentation mean Dice score was 0.675 for the suggested model. Renal cell carcinoma classification was 0.885 accurate. (4) Conclusion and key findings: The present study focused on analyzing data from both healthy patients and diseased renal patients, with a particular emphasis on data processing. The method achieved a kidney segmentation accuracy of 0.84 and mean Dice scores of 0.675 for tumor segmentation. The system performed well in classifying renal cell carcinoma, achieving an accuracy of 0.885, results which indicates that the technique has the potential to improve the diagnosis of kidney pathology.

Keywords: ECVL; EDDL; European Deep Health toolkit; artificial intelligence; convolutional neural network; image classification; image segmentation; kidney tumor; renal cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. Robert-Andrei Dobran is an employee of the company SIMAVI.

Figures

Figure 1
Figure 1
U-net model used.
Figure 2
Figure 2
(a)—ResNet101 part 1. (b)—ResNet101 part 2. (c)—ResNet101 part 3.
Figure 3
Figure 3
CT image of a healthy kidney (a); the medical expert segmentation (shown in white) (b); and the result of the model’s prediction (c).
Figure 4
Figure 4
CT image of a kidney with clear cell renal cell carcinoma (a); the medical expert tumor segmentation (shown in white) (b); and the result of the tumor location prediction (c).

References

    1. Warren A.Y., Harrison D. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: Standards and controversies. World J. Urol. 2018;36:1913–1926. doi: 10.1007/s00345-018-2447-8. - DOI - PMC - PubMed
    1. Capitanio U., Bensalah K., Bex A., Boorjian S.A., Bray F., Coleman J., Gore J.L., Sun M., Wood C., Russo P. Epidemiology of Renal Cell Carcinoma. Eur. Urol. 2019;75:74–84. doi: 10.1016/j.eururo.2018.08.036. - DOI - PMC - PubMed
    1. Padala S.A., Barsouk A., Thandra K.C., Saginala K., Mohammed A., Vakiti A., Rawla P., Barsouk A. Epidemiology of Renal Cell Carcinoma. World J. Oncol. 2020;11:79–87. doi: 10.14740/wjon1279. - DOI - PMC - PubMed
    1. Kowalewski K.-F., Egen L., Fischetti C.E., Puliatti S., Juan G.R., Taratkin M., Ines R.B., Abate M.A.S., Mühlbauer J., Wessels F., et al. Artificial intelligence for renal cancer: From imaging to histology and beyond. Asian J. Urol. 2022;9:243–252. doi: 10.1016/j.ajur.2022.05.003. - DOI - PMC - PubMed
    1. Chin A.I., Lam J.S., Figlin R.A., Belldegrun A.S. Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev. Urol. 2006;8:1–7. - PMC - PubMed

LinkOut - more resources